Digital therapeutics company Kaia Health announces results from its ongoing Rise-uP randomized controlled trial (RCT), demonstrating that its musculoskeletal (MSK) solution reduces costs by 80% when compared with standard-of-care treatments.
/PRNewswire/ Kaia Health, the digital therapeutics company on a mission to democratize access to high-quality healthcare, today announced clinical trial.
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news or the bad from your shop, and we will feature it here at the end of each week.
Kaia Health announces the appointment of Nigel Ohrenstein healthcare entrepreneur and Lumeris co-founder as president to accelerate the growth and further advance Kaia Health’s strategy as a provider musculoskeletal (MSK) care.